How Jintara Treats Bipolar Disorder and Addiction Together

When bipolar disorder and addiction feed each other, treating one and missing the other is the most common reason people relapse. Bipolar disorder is a mood condition of alternating mania and depression, and because the two interact so relentlessly, psychiatric assessment at Jintara begins on the first day rather than weeks in. Research from the National Institute of Mental Health and NIDA both show how consistently a mood disorder and substance use travel together, so treating only one rarely leads to lasting recovery. During manic and hypomanic episodes, impulsivity rises sharply, and substances are often used in ways that feel coherent in the moment. During depressive episodes, alcohol, cannabis, or sedatives are commonly used to reduce the weight of low mood.

Each pattern of use then interferes with the mood cycle itself, making episodes more frequent, more severe, and harder to predict. For a person trying to get sober, an unaddressed mood disorder makes early recovery feel unmanageable. For a person managing bipolar disorder, active substance use disrupts medication, disturbs sleep, and can trigger episodes that might otherwise have been preventable. This is why one team treats both conditions in the same plan, rather than treating the addiction and sending the mood swings home untreated.

Alcohol and stimulants are the substances most commonly associated with bipolar disorder, and each one reshapes the mood cycle in a specific way. Alcohol temporarily blunts the agitation of a manic episode but deepens depressive phases considerably, disrupting the sleep architecture that mood stabilisation depends on. Cannabis use in people with bipolar disorder is associated with earlier onset of mood episodes and less predictable cycling, a pattern that can intensify during the medical detox process when withdrawal itself shifts mood. Stimulants including cocaine and methamphetamine sit at the other end, capable of triggering or prolonging a manic episode in someone with an underlying mood vulnerability.

The clinical challenge is that active substance use produces mood symptoms that can look identical to bipolar disorder. Paranoia, grandiosity, racing thoughts, and profound low mood can all be caused by substances alone, by bipolar disorder alone, or by both at once. This overlap is why psychiatric assessment cannot be completed reliably at intake alone. A diagnosis formed before detox is complete carries a significant risk of being inaccurate.

Accurate diagnosis in this population depends on seeing a person's mental state without the interference of substances. Many clients arrive at Jintara with a self-reported bipolar diagnosis that has not been clinically confirmed, and the same diagnostic uncertainty affects clients presenting with anxiety alongside addiction, where substances can mask or mimic more than one condition at once. Darren Lockie, Jintara's founder, describes a pattern the team sees regularly, where people arrive with a preconceived idea of what they have and the clinical picture changes once substances are removed. That gap between what a person believes and what the clinical picture shows is exactly what the assessment process is built to close.

Some clients find that mood symptoms resolve entirely once they are off substances. Others arrive unaware they have an underlying mood disorder that has been masked by years of use. Jintara's psychiatric assessment process does not arrive at a fixed mood diagnosis in the first week. The clinical position is that the team needs to see a person's baseline mental state, without the interference of substances, before attaching a permanent psychiatric label. Assessment is an ongoing process across the first two weeks, not a form completed on arrival.

Every client at Jintara has a psychiatrist-led assessment on arrival, and it is far more than a screening questionnaire. It is a thorough clinical interview covering substance history, mood history, medication compliance, previous psychiatric admissions, current risk, and family history, in line with SAMHSA's clinical guidance on co-occurring disorders. Clients receive a written outline of what to bring through the admissions process at Jintara, and the assessment may be followed by five or more further psychiatric reviews during a 30-day stay where medication adjustment is indicated. Nothing about the mood picture is treated as settled on the first day.

For clients with bipolar disorder, the assessment serves two functions. First, it establishes the current medication regimen and confirms that the existing mood stabiliser will be continued without interruption. Second, it provides a baseline picture of mood at intake, which is then compared against how mood presents once the acute phase of detox resolves. This comparison can confirm a bipolar diagnosis, revise it, or flag that further outpatient psychiatric review is needed after discharge.

A common fear for people with medicated bipolar disorder is that a residential setting will change or stop their psychiatric medication, and at Jintara that does not happen unilaterally. Existing mood stabilisers, whether lithium, valproate, carbamazepine, or an atypical antipsychotic, are reviewed and continued throughout the stay. Psychiatric assessment and medication management are included in the program fee at Jintara, not billed separately as at many competitors. The psychiatrist may recommend an adjustment if a drug interaction with detox medications presents a clinical concern, but any change is discussed with the client and documented.

What Jintara does not offer is mood stabiliser initiation for clients who have not previously been diagnosed or treated. If the assessment process suggests a mood disorder that was not previously treated, the team documents this observation and recommends outpatient psychiatric follow-up after discharge. Starting a new mood stabiliser in the middle of a 30-day addiction treatment program is not clinically appropriate in most cases.

The practical implication is simple. Arrive with your existing medication and a recent prescription or clinical note confirming your regimen, and the medical team incorporates it into your treatment plan from the first day.

Individual therapy for clients with bipolar disorder targets the patterns that link mood instability to substance use. Within the full therapy program at Jintara, therapists with postgraduate qualifications, each holding a master's degree in counselling, psychology, or a related clinical field, help clients identify manic and depressive triggers, build the sleep and daily structure that supports mood regulation, and understand why medication adherence matters over the long term. That daily structure is as much a part of the clinical work as any single session.

Group therapy is a mandatory part of the program. The group setting provides peer support, psycho-education, and the chance to practise the social skills that mood episodes and substance use tend to erode. Cognitive behavioural therapy runs across both individual and group formats to address the thought patterns that link mood states to substance use decisions. The therapy does not promise to eliminate mood episodes; it builds the skills and support structures that make episodes less likely to end in relapse.

Jintara accepts clients who have a diagnosed bipolar disorder, are currently medicated, and are willing to maintain their medication throughout treatment. This group can be supported within the 30-day program, and the admissions team is candid about what Jintara does and does not treat so that people reach the setting that genuinely fits. Psychiatric oversight and therapy then address both the mood disorder and the substance use together.

Jintara does not accept clients who have unmedicated bipolar disorder and are unwilling or unable to take medication during treatment. The clinical reason is straightforward. An active untreated manic or depressive episode requires a level of psychiatric containment that goes beyond what a residential addiction program can safely provide. Referral is made promptly and without judgment.

If there is uncertainty about whether a bipolar diagnosis is accurate, that can be explored during the assessment process, provided the client is medically stable at intake.